Risk Factors for Chronic Kidney Disease in Adults with Cystic Fibrosis
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale: Adults with cystic fibrosis (CF) possess multiple potential risk factors for chronic kidney disease, including CF-related diabetes (CFRD) and lifetime nephrotoxic drug exposure. Objectives: To determine whether cumulative intravenous (IV) aminoglycoside exposure and CFRD increase the risk of chronic kidney disease in adults with CF. Methods: This was a cohort study using adults (≥ 18 yr) in the CF Foundation registry from 2001–2008. Chronic kidney disease (stage 3 or greater) was defined by an estimated glomerular filtration rate of less than 60 ml/min/1.73 m2. Time-dependent multivariable Cox proportional hazards models were used to determine whether cumulative number of acute pulmonary exacerbations (surrogate for IV aminoglycoside exposure) and CFRD requiring insulin increase the risk of chronic kidney disease, adjusting for confounders. Measurements and Main Results: The study cohort included 11,912 adults with a median follow-up of 4 years. During the study period, 204 subjects had chronic kidney disease, with an annual disease prevalence of 2.3%. Disease prevalence doubled with every 10-year increase in age. CFRD requiring insulin therapy substantially increased the risk of chronic kidney disease (1–4 yr of CFRD requiring insulin vs. no CFRD, hazard ratio [HR] = 2.40, 95% confidence interval [CI] 1.74–3.32; ≥ 5 yr, HR = 4.56, 95% CI 2.84–7.31). Pulmonary exacerbations did not significantly increase the risk of chronic kidney disease (one to five exacerbations vs. none, HR = 0.79, 95% CI 0.56–1.11; six to nine exacerbations, HR = 0.92, 95% CI 0.58–1.46; ≥ 10 exacerbations, HR = 1.16, 95% CI 0.75–1.81). Conclusions: CF-related diabetes is a significant risk factor for chronic kidney disease in adults with CF, but additional studies examining IV aminoglycoside exposure directly are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The CF population may differ from the non-CF population given their young age, the impact of persistent CF transmembrane conductance regulatory (CFTR) dysfunction in other key organs like gut and liver, and their increased risk of complications such as CF-related diabetes and renal dysfunction from chronic aminoglycoside use.10,11”
From Cystic fibrosis survival outcomes following second lung transplant: The north American experience (2023) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309 · cited 1×
“Renal function was estimated using the Cockcroft-Gault formula standardized for body surface area (12, 13).”
MethodPrevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · cited 1×
“Our age-adjusted prevalence estimates for CKD (stage 3 or greater) are about twofold higher than estimates from the United States general population using 1999–2004 National Health and Nutrition Examination Survey data (17).”
BackgroundSimplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238 · cited 1×
“Renal function was estimated using the Cockcroft-Gault formula standardized for body surface area (12, 13).”
MethodIntermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241 · cited 2×
“Previous studies in the general population have shown that advanced age is an independent risk factor for CKD (7, 16).”
BackgroundOrens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
The changing epidemiology of cystic fibrosis
FitzSimmons, S. C. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83478-x · Cited by 928
New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view
Lopez-Novoa, J. M., Quiros, Y., Vicente, L., Morales, A. I., & Lopez-Hernandez, F. J. (2011) · Kidney International · doi:10.1038/ki.2010.337 · Cited by 753 · cited 1×
“In addition to tubular damage, renal vasoconstriction and mesangial contraction are suspected to play important roles at the glomerular level (22).”
BackgroundClinical Care Guidelines for Cystic Fibrosis–Related Diabetes
Moran, A., Brunzell, C., Cohen, R. C., Katz, M., Marshall, B. C., Onady, G., Robinson, K. A., Sabadosa, K. A., Stecenko, A., Slovis, B., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1768 · Cited by 726 · cited 2×
“This key finding is interesting in light of a recent statement on behalf of the American Diabetes Association and CF-related Diabetes Consensus Report Committee that the “kidneys may be somewhat protected in CFRD” because of residual insulin secretion, and the absence of other known risk factors for microvascular dise…”
BackgroundResult
Research works printed but not linked: 2
- Cystic Fibrosis Foundation Patient Registry 2009 Annual Data Report. Bethesda, Maryland: Cystic Fibrosis Foundation; 2011 [Google Scholar]
- National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1–S266 [PubMed] [Google Scholar]
Cited by
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Self-citationECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
Self-citationEuropean cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
“Chronic kidney disease (CKD) occurs in many adults with CF and where practical, limiting exposure to nephrotoxic drugs pre-transplant should be considered [95].”
BackgroundSelf-citationMacKenzie, T., Gifford, A. H., Sabadosa, K. A., Quinton, H. B., Knapp, E. A., Goss, C. H., & Marshall, B. C. (2014) · Annals of Internal Medicine · doi:10.7326/m13-0636 · Cited by 355
“reports have emphasized that chronic renal insufficiency (40), hypertriglyceridemia (41), and colon cancer (42) affect adults with CF at higher rates than those without it.”
Self-citationKapnadak, S. G., Dimango, E., Hadjiliadis, D., Hempstead, S. E., Tallarico, E., Pilewski, J. M., Faro, A., Albright, J., Benden, C., Blair, S., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.02.015 · Cited by 157
Metadata
- Authors
- Quon, B. S., Mayer-Hamblett, N., Aitken, M. L., Smyth, A. R., & Goss, C. H.
- Affiliations
- University of British Columbia (CA)
- Seattle Children's Hospital (US)
- University of Washington (US)
- University of Nottingham (GB)
- Corresponding author
- Quon, Bradley S.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11
- Volume
- 184
- Issue
- 10
- Pages
- 1147-1152
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3262023
- OpenAlex
- W2000669626
- Cited by
- 90
- References
- 34
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 9 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 4
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Columbia Lung Association
- National Institute for Health and Care Research (PB-PG-1207-15025)
- National Institutes of Health (P30 DK 089,507, DK089507)
- National Heart, Lung, and Blood Institute (R01HL103965)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK089507, P30DK089507)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- cystic fibrosis, chronic kidney disease, CF-related diabetes, aminoglycoside nephrotoxicity, pulmonary exacerbations, insulin therapy, risk factors, adults with cystic fibrosis, estimated glomerular filtration rate
- MeSH terms
- Adolescent, Adult, Age Factors, Aminoglycosides, Anti-Bacterial Agents, Cystic Fibrosis, Diabetic Nephropathies, Female, Humans, Injections, Intravenous, Kidney Failure, Chronic, Longitudinal Studies, Male, Middle Aged, Risk Factors, Time Factors, Prevalence, Confidence Intervals, Proportional Hazards Models, Young Adult, Glomerular Filtration Barrier
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk Factors for Chronic Kidney Disease in Adults with Cystic Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201105-0932oc
- The paper
- Quon, B. S., Mayer-Hamblett, N., Aitken, M. L., Smyth, A. R., & Goss, C. H. (2011). Risk Factors for Chronic Kidney Disease in Adults with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201105-0932oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.